key: cord-1022069-one9e9wt
authors: Rahman, Heshu Sulaiman; Aziz, Masrur Sleman; Hussein, Ridha Hassan; Othman, Hemn Hassan; Salih Omer, Shirwan Hama; Khalid, Eman Star; Abdulrahman, Nusayba Abdulrazaq; Amin, Kawa; Abdullah, Rasedee
title: The Transmission Modes and Sources of COVID-19: A Systematic Review
date: 2020-09-11
journal: International journal of surgery open
DOI: 10.1016/j.ijso.2020.08.017
sha: a0c09d53ca40104a4ff8d61f1874bf6dc84499a4
doc_id: 1022069
cord_uid: one9e9wt

The current rampant coronavirus infection in humans, commonly known as COVID-19, a pandemic that may cause mortality in humans, has been declared a global emergency by the World Health Organization (WHO). The morbidity and mortality rates due to the pandemic are increasing rapidly worldwide, with the USA most affected by the disease. The source COVID-19 is not absolutely clear; however, the disease may be transmitted by either by COVID-19-positive individuals or from a contaminated environment. In this review, we focused on how the COVID-19 virus is transmitted in the community. An extensive literature search was conducted using specific keywords and criteria. Based on the published report, it is concluded that COVID-19 is primarily transmitted human-to-human via oral and respiratory aerosols and droplets with the virus-contaminated environment play a lesser role in the propagation of disease. Healthcare providers and the elderly with comorbidities are especially susceptible to the infection.

may occur but less commonly reported 16 . It is now known that patients can be infected with the virus without showing any symptoms. However, most COVID-19 cases have good prognoses with mild symptoms, and with supportive care, they recovered after 7 -10 days of hospitalization 17 . Patients that developed pulmonary edema, acute respiratory distress syndrome (ARDS), multiple organ failure, may die from the infection 18 .

There are several tests available for COVID-19 diagnosis, mostly based on molecular or serological methods. The molecular methods are Real-time Polymerase Chain Reaction (PCR) and E gene PCR. These tests have been effective in the detection of COVID-19 infections from respiratory secretion samples. However, confirmation of the PCR test result may be required, and this can be done by sequencing the RNA-dependent RNA polymerase (RdRp) gene 19, 20 . The serological tests are used to determine the presence of antibodies to the coronavirus, in patients who recovered from COVID-19, or those that may have been acquired the disease but showing mild or no symptoms 21 .

At present, there is no proven antiviral medication available for COVID-19. The current treatment method for infected patients is mainly supportive care 1, 22 . However, it was reported that patients at Jinyintan Hospital in Wuhan, China treated with oral doses of oseltamivir, lopinavir, and ritonavir tablets and intravenous injection of ganciclovir showed faster recovery rate 18, 23 . On the other hand, dexamethasone lowered 4 weeks of mortality among hospitalized patients that received either invasive mechanical ventilation or oxygen alone at randomization but not among those received no respiratory support 24 . Additionally, alpha-interferon, a combination of Hydroxychloroquine and azithromycin, arbidol, favipiravir were given some critical recovery rate in various countries 25 . In contrast, remdesivir touted as the savior drug for COVID-19 patients but failed in the first clinical trial 26 .

Risk factors for transmission of COVID-19 are largely uncharacterized 27 . However, to avoid the spread of COVID-19, the CDC and WHO have instituted a preparedness and prevention agenda for the infection to be used by the public, first-responders, and healthcare providers and professionals 28, 29 . Although this agenda is somewhat practiced by hospitals with confirmed COVID-19 patients, the general population is not completely compliant, thus, putting them at J o u r n a l P r e -p r o o f extremely high risk of exposure to the infections from colleagues, household members, and the community 27, 30 .

Clusters of local transmission must be identified 31, 32 to improve control of spread through preparedness, readiness, and response actions 33 . Control of the spread of COVID-19 also requires precise information on human mobility, epidemiological, and genetic data at local, regional, and global levels. This information will ensure success in the deployment of resources in the mitigation of COVID-19 transmission 30, 34 .

Treatment and control of viral disease are complicated by the propensity of the virus to mutate, making development and deployment anti-viral vaccines very challenging 35, 36 . In this regard, a recent study reported the initial analysis of APOBEC and ADAR deaminase-mediated mutation signature patterns in complete COVID-19 genomes from informative locations and times in China, USA and Spain identified a unique set of new putative coordinated Riboswitches in COVID-19 genomes and variants in common strain Haplotypes. The results reveal that COVID-19 diversifies using switching of RNA Haplotypes with minimal alteration to protein structure 37 .

Thus, vaccine designs that assume that the main viral protein antigens will be the only putative protective targets could fail to produce effective and protective immunity. Therefore, the challenges for targeted drug and vaccine development for COVID-19 needs understanding COVID-19 adaptation and survival strategy and identifying the host Haplotype, and which vaccine(s) is effective for each Haplotype group 37 .

However, there are other alternative means to control COVID-19 infection and preventing transmission. This can be done implementing containment, which includes isolation of known cases, quarantine of persons believed at high risk of exposure, especially during the initial phase of the outbreak, and closing regional and country borders and restricting movement and travel and screening travelers for the infection 2, 38, 39 . As the last resort and if necessary, the community could be placed on complete lockdown 40 .

The exact source of the COVID-19 virus remains elusive 41 . To ensure that the pandemic can be curtailed, the source and mode of transmission of the infection must be precisely determined.

Thus, in this review, we focused on the causative agent, the main modes of transmission, and sources of COVID-19. Several pertinent online databases including PubMed, Google Scholar, Scopus, bioRxiv, medRxiv, and chemRxiv were searched to collect relevant data. Information from some articles published online by the Chinese Center for Disease Prevention and Control, and the WHO was also included in the review.

All publications available in peer-reviewed journals, review, practical and technical articles addressing the main routes, modes, and sources of COVID-19 virus transmission in humans were selected, inclusive of full review articles, practical, and technical papers.

Case reports, editorials, letters, letters to the editor, comments/commentaries, short/brief communications, rapid reviews, short/rapid reports, opinions, news, seminars, features, correspondences, exercises, protocols, guidance, highlights, forums, images, interviews, insights, panels, symposia, abstracts, personal views, perspectives, preprints, podiums, policies, consensus documents, and practices were excluded from the review.

Gathering of publications from websites was done with the Medical Subject Heading (MeSH) using terms such as new Coronavirus, novel Coronavirus, COVID-19, 2019-nCov, SARS-Coronavirus-2, SARS-CoV-2, MERS-Coronavirus-2, and MERS-CoV-2. Keywords from the title of the subject matter, such as COVID-19 mode of transmission, route of transmission of COVID-19, and source of COVID-19, COVID-19 viral load, and shedding were also used. To ensure that all relevant researches are including, the following terms were used in combination with COVID-19: transmission, spread, source, viral load, viral shed, infection, respiratory illness, pneumonia, outbreak, pandemic, quarantine, and lockdown. The titles, author list, and abstracts of these publications were evaluated to avoid data duplication.

Data from selected publications were extracted and documented in the excel spreadsheet.

A total number of 2,036 of publications were identified. Among these publications, 235 were duplicated studies and excluded. The remaining 1,801 publications were scrutinized based on exclusion criteria, and as a result, 1,071 publications were removed from the study. The remaining 730 articles were again screened and finally, only 151 publications were found relevant included in the review (Figure 1 ). 43 . The virus is related to some β-coronaviruses genera in bats [43] [44] [45] .

After examination of approximately 169 genomes, the COVID-19 virus can be classified into two major genotypes, namely, Type I (A and B) and II. Based on the phylogenetic investigation, Type IA almost appeared like the ancestral COVID-19 virus. Type II, which evolved from Type I, is a predominant and highly contagious form of the virus, and this virus is suggested to be one responsible for the epidemic that began in the wet-market of Wuhan City, China. People with COVID-19 that did not have direct contact with the Wuhan marketplace may have been infected with the Type I virus 46 .

J o u r n a l P r e -p r o o f

The character and trends of current COVID-19 transmission can be used as indicators of how the COVID-19 pandemic will behave throughout the rest of 2020 and in the following years 7 .

The transmission of COVID-19 in humans is no clear 47 , although early in the pandemic, it was declared that the infection is zoonotic 48 , that is, from animals to human 43, 49, 50 . Recently, many patients without a history of exposure to the marketplace in Wuhan, China, or animals elsewhere and medical professionals had contracted the disease, which indicates that the infection is not merely animal-to-human transmission, instead, it may occur between humans 16, 58-60 . This mode of transmission of the disease appears to be similar to SARS and MERS, known to infect and spread among humans through close contact and respiratory droplets from coughs and sneezes 11 . Whether COVID-19 behavior is similar to SARS or MERS needs further investigations.

Current data showed that there is the human-to-human transmission of COVID-19 61 , suggesting that to be the main mode of transmission of the disease in the current pandemic 62 . Thus, there is J o u r n a l P r e -p r o o f a need for rigorous surveillance and testing to prevent further expansion of the pandemic 63-65 .

Generally, patients showing symptoms of COVID-19 will spread the disease to those in close contact 66, 67 . However, many COVID-19 patients are asymptomatic and can serve as carriers and unknowingly transmit the virus [68] [69] [70] . This may be the reason for the number of COVID-19 cases increased drastically and rapidly in some societies that lax in the practice of isolation and social distancing 59, 71, 72 , and within families with asymptomatic infected individuals 73 ( Figure 2 ).

The COVID-19 is a fast expanding pandemic, which caught many countries off-guard. In many countries, the control of the infection is hindered by inadequate emergency settings, suboptimal logistics, and scarcity of personal protective equipment (PPE) 74 . This had endangered front liners and healthcare providers that were directly involved in the handling of COVID-19 cases.

This situation suggests the need for other treatment means, like telemedicine, which is ideal for medical practitioners to evaluate, diagnose and treat patients from a distance, thus, while avoiding contact with and exposure to infected patients 66, 67 . Telemedicine is especially ideal because 75, 76 physicians can simultaneously attend to patients at several distant locations. In pandemics, where the medical practitioners are stretched to provide services, telemedicine will serve to provide the means to obtain the much need medical attention to a large number of patients 77 .

Currently, it is difficult to determine whether a COVID-19 case is imported, secondary, and the result of tertiary transmission 78, 79 . However, there are confirmed cases of secondary and tertiary transmission of COVID-19 80, 81 , and these cases are believed to be the leading causes for rapid cycles of disease transmission from one generation to the next 35 . There are now many pieces of evidence of chains of at least four generations (highest level of first-generation) infections, which unequivocal suggest the existence of sustained human-to-human transmission 63, 82-84 .

This type of human-to-human COVID-19 transmission includes:

Based on the latest guidelines from Chinese health authorities, there are 3 main transmission routes for the COVID-19 virus in humans 85-87 , namely direct contact, aerosol, and droplets.

Direct contact transmission may occur through direct contact with virus-contaminated objects or surfaces and infecting people through the mouth, nose, or eyes 88, 89 . Healthcare providers attending COVID-19 patients are especially at risk of being infected via this mode of disease transmission 84 , one reason there are numerous nosocomial infections 54, 86 . In direct contact transmission, the fomites are suspected to be the main source of infectious particles 90, 91 . The transmission of COVID-19 can be minimized by frequent washing of hands with an alcoholbased hand rub or soap and water and avoiding touching eyes, nose, and mouth with contaminated hands 92 .

Although the COVID-19 virus is not principally an airborne virus 93 , the aerosols from expired air coughs, and sneezes that contaminate the immediate environment 88, 89 are among media for virus spread [94] [95] [96] . Aerosol transmission is not just from people with symptoms of the disease, even asymptomatic COVID-19-positive people can be the source of infection 69, 97 . In close environments, the virus-containing aerosol may persist in the air for long periods and at high concentrations, further increasing the rate of transmission 82 . The virus remains viable for at least 3 hours in aerosols and 48 to 72 hours on stainless steel and plastic surfaces 98 .

Nosocomial transmission of the COVID-19 99 is a serious threat to healthcare providers.

Nosocomial infections through aerosols can occur when they perform procedures on the respiratory pathway, perform dental care 94 

Respiratory air normally contains an abundance of droplets of sizes less than 5 μm in diameter.

Coughing and sneezing cause increased expulsion of droplets from the oral cavity and respiratory tract. In COVID-19 patients these droplets contain a virus that if inhaled or ingested or landing on the mucous membranes will cause disease in people 98, 105 . This mode transmission is the most dangerous form of COVID-19 spread among healthcare providers 106 . The use of PPE with efficient barriers to the droplets and maintenance of personal and environmental hygiene will limit the rate of infections 107 .

COVID-19 viral transmission may also occur via feces, tears, and conjunctival secretions 101, 108-110 .

The role of feces in the transmission of COVID-19 is unclear 111 . There have been suggestions that the gastrointestinal system is a critical route for the spread of this virus 112 . The COVID-19 virus infects cells via the surface angiotensin-converting enzyme 2 (ACE2). Incidentally, it was shown that there are high expressions of ACE2 in gastric glandular, colon and ileum absorptive enterocytes, duodenal and rectal cells suggesting the virus spread via the fecal-oral route 97, 113, 107 . It seems, that using immunofluorescent staining, the ACE2-positive cells are rarely detected in esophageal mucosa. This is probably of the predominance of esophageal squamous epithelial cells that express less ACE2 than glandular epithelial cells 114 .

Specimens collected from the surface of the toilet bowl, in the sink, and the door handles of toilets used COVID-19-positive patients without diarrhea, were all positive for the virus 108 .

However, these toilets were negative for the virus after it has been thoroughly sanitized. 

The COVID-19 virus resides principally in the respiratory tract and its secretions. These pose risks to healthcare providers if these patients require surgery. This is particularly true in organ transplantation procedures. Recipients of organs, especially, because being place in the immunocompromised state, which is necessary for the procedure, are at high risk of being infected with COVID-19 17, 118 . Thus, unless necessary, it would be advisable to delay organ transplantation procedures until the COVID-19 pandemic has gone through its full course and no longer a health threat. However, emergency surgical interventions should be followed in the COVID-19 population in case of severe appendicitis; abortions that need caesarian section, strangulated inguinal hernias, intestinal/respiratory obstructions, severe toothache, aggressive tumor, painful kidney stone and even severe trauma caused by a gunshot or car accident 119 .

Although until the beginning of April 2020 there was no published data on cases of transmission of COVID-19 from patients to surgeons, healthcare providers, and other hospitalized patients during the surgical operation, hospitalization, and treatment 120 . But later on, it was confirmed by the Chinese Center for Disease Control and Prevention that 3.8% of reported cases were healthcare personnel from which 15% were classified as severe cases with only 0.2% mortality rate. In COVID-19 patients, there is an evidence of the virus in the sputum (93%), blood (1%), stool (29%), and maybe some organs contain the virus, which may expose surgeons, or operating room staff 121 . Taken together, this suggests that pulmonary and upper respiratory surgeries are J o u r n a l P r e -p r o o f likely to be higher risk, but that colorectal and gastrointestinal surgeries may also have a greater risk of transmission 122 .

The COVID-19 pandemic puts pregnant women and fetuses at risk of being infected by the virus. This is primarily due to the high expression of ACE2 receptors in the human maternal-fetal interphase. This ACE2 receptor structure of the COVID-19 virus is analogous to that of SARS. 

The pathophysiological characteristics of COVID-19 have not been determined and there is much uncertainty regarding the mechanism of shedding and spread of the virus 136, 137 . Recent J o u r n a l P r e -p r o o f 13 estimates suggested that COVID-19 has a median incubation period of 3 days (range: 0-24 days) 138 with potential asymptomatic transmission 139, 140 . Epidemiological evidence showed the virus can be transmitted during the incubation period 141 , especially during the late stages 142 .

Interestingly, the viral could not be detected early in diseased patients from the tertiary transmission, thus, it could be speculated that the infectivity of COVID-19 will gradually decrease with the level of transmission 143 [153] [154] [155] . Healthcare providers are at high risk of acquiring the disease, thus, must be subjected to regular testing, practice self-monitor, report signs of illness, and voluntarily isolate themselves if they exhibit symptoms of COVID-19 94, 156 . Since the COVID-19 virus is known to survive on surfaces for hours or days 157 , the healthcare providers must practice strict hygiene, regularly and conscientiously cleaning workspaces and personal items such as stethoscopes, mobile phones, keyboards, dictation devices, landlines, and nametags. The hospital must provide disinfectants for the use of personnel and patients 158 .

The testing strategies that should be followed to prevent COVID-19 vertical/horizontal modes of transmission during surgery include detection of the viral RNA using Polymerase Chain Reaction (PCR) and detection of the host's response (antibodies) to the virus using serological techniques 159 .

The former technique is more accurate and considered as a gold standard for this virus using swabs from the nasopharynx and/or oropharynx. Since COVID-19 can infect anyone and result in transmission before the onset of symptoms or even without individuals ever developing symptoms, testing/screening of asymptomatic patients has been considered 160 .

Whereas, the latter includes detection of IgM, IgA, IgG, or total antibodies in the blood although this virus is not typically present in blood in which COVID-19 infection causes white blood cells (WBC) to make antibody proteins that help the immune system identify the viruses and stop them or mark infected cells for destruction. This process is host-dependent and takes 7-11 days after exposure to the virus, although some patients may develop antibodies sooner. Therefore, this technique is not useful in the setting of an acute infection 159 .

Standard surgical personal protective equipment (PPE) includes a face shield, high-performance filtering mask, waterproof gown, double gloves, and shoe covers that must be implemented properly (Table 1) 161 . However, there is some disagreement about the type of respiratory protection N95 respirator, powered air-purifying respirator (PAPR), and standard surgical mask that should be used for surgical procedures on patients with COVID-19. Mask is considered as the main item of PPE as it is easy to obtain, cheap, and available in almost all hospitals including J o u r n a l P r e -p r o o f low-income countries. A surgical mask is capable of blocking the gross inhalation of respiratory droplets, while a well-fitted N95 respirator is proficient in filtering aerosols 162, 163 . On the other hand, high-performance filtering masks including FFP1, FFP2, and FFP3 masks have a high filtration efficiency of 80%, 94%, and 99% respectively, while N95 mask blocks at least 95% of solid and liquid aerosol test particles. Thus, the FFP3 is likely to be twice as effective as the FFP2 mask, and broadly both are equivalent or superior to an N95 mask.

In this regard, a study in 4 hospitals at Wuhan, China on 420 fully protected (implemented appropriate PPE) healthcare professionals (116 doctors 

Kucharski AJ, Russell TW, Diamond C, Funk S, Eggo RM, group Cnw. Early dynamics of transmission and control of 2019-nCoV: a mathematical modelling study. medRxiv 2020. 

Zhou P, Yang X-L, Wang X-G, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv 2020.

Ji W, Wang W, Zhao X, Zai J, Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol 2020.

Wong MC, Cregeen SJJ, Ajami NJ, Petrosino JF. Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019. Biorxiv 2020.

Xiao 

Imai N, Dorigatti I, Cori A, Riley S, Ferguson N. Estimating the potential total number of novel Coronavirus cases in Wuhan City, China. 2020.

Ung COL. Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak. Research in Social and Administrative Pharmacy 2020.

Novel Coronavirus (2019-nCoV)2020

Quarantine for SARS-CoV-2 in Spain: How Did We Do it?

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status

Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China

Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

Epidemiologic and Clinical Characteristics of 91

Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series

Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America

SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan. medRxiv 2020. 11. China NHCoPsRo

Molecular diversity of coronaviruses in bats

Isolation and molecular characterization of

Sul/01/09 avian infectious bronchitis virus, indicates the emergence of a new genotype in the Middle East

SARS and other coronaviruses as causes of pneumonia

Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Characteristics of COVID-19 infection in Beijing

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Coronavirus disease 2019 (COVID-19): a clinical update

2019-nCoV (Wuhan virus), a novel Coronavirus: humanto-human transmission, travel-related cases, and vaccine readiness

Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak

COVID-19-the role of mass gatherings. Travel medicine and infectious disease

Transmission and epidemiological characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected Pneumonia (COVID-19): preliminary evidence obtained in comparison with 2003-SARS. medRxiv 2020. 42. Prevention CCfDCa. 585 environmental samples from the South China Seafood Market in Wuhan

Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle

Molecular basis of COVID-19 relationships in different species: a one health perspective. Microbes and Infection

A mathematical model for simulating the phase-based transmissibility of a novel coronavirus

Genomic variations of SARS-CoV-2 suggest multiple outbreak sources of transmission

On the origin and continuing evolution of SARS-CoV-2

A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action

The 2019-new coronavirus epidemic: evidence for virus evolution

Pathogenicity and transmissibility of 2019-nCoV-a quick overview and comparison with other emerging viruses. Microbes and infection

Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2

2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies

Risk assessment of novel coronavirus COVID-19 outbreaks outside

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

Evaluating new evidence in the early dynamics of the novel coronavirus COVID-19 outbreak in Wuhan, China with real time domestic traffic and potential asymptomatic transmissions

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China

Pattern of early human-to-human transmission of Wuhan

Respiratory Therapy Group CMARB. Expert consensus on respiratory therapy related to new Coronavirus infection in severe and critical patients

The outbreak of COVID-19: An overview

Spatial transmission of COVID-19 via public and private transportation in China

Risk factors of healthcare workers with corona virus disease 2019: A retrospective cohort study in a designated hospital of Wuhan in China

Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic

Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19

First cases of coronavirus disease

in France: surveillance, investigations and control measures

Serial interval of novel coronavirus (COVID-19) infections

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

The SARS-CoV-2 outbreak: what we know

Transmission potential and severity of COVID-19 in South Korea

Potential of large "first generation" human-to-human transmission of 2019-nCoV

Coronavirus disease (COVID-19) and neonate: What neonatologist need to know

Epidemiological and clinical characteristics of SARS-CoV-2 and SARS-CoV: a system review

Ocular tropism of respiratory viruses

2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus

Review of the clinical characteristics of coronavirus disease 2019 (COVID-19)

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

A review of coronavirus disease-2019 (COVID-19)

Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore

Transmission routes of 2019-nCoV and controls in dental practice

The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19

Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists

Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres

Detection of SARS-CoV-2 in different types of clinical specimens

Consensus guidelines for managing the airway in patients with COVID-19

Association between 2019-nCoV transmission and N95 respirator use

Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals

Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China

Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review

What we know so far: COVID-19 current clinical knowledge and research

Coronavirus disease 2019: coronaviruses and blood safety

COVID-19 and blood safety: help with a dilemma

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child

Eleven faces of coronavirus disease 2019

The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes

Evidence for gastrointestinal infection of SARS-CoV-2

A new transmission route for the propagation of the SARS-CoV-2 coronavirus

SARS-CoV-2 may persist in digestive tract longer than respiratory tract

Prolonged presence of SARS-CoV-2 in feces of pediatric patients during the convalescent phase

COVID-19: A Global Transplant Perspective on Successfully Navigating a Pandemic

Emergency general surgery in Italy during the COVID-19 outbreak: first survey from the real life

Detection of SARS-CoV-2 in different types of clinical specimens

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Personal protective equipment and Covid

ACE2 expression and activity are enhanced during pregnancy

The ACE2 expression of maternal-fetal interface and fetal organs indicates potential risk of vertical transmission of SARS-COV-2

Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn

Severe COVID-19 during pregnancy and possible vertical transmission

A Pregnant Mother Infected with the Coronavirus Gave Birth, and Her Baby Tested Positive 30 Hours Later

Newborn baby tests positive for coronavirus in London

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review

Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS): No. 225

Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection

Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals

Obstetricians RCo, Gynaecologists. Coronavirus (COVID-19) infection in pregnancy

Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

The novel coronavirus-a snapshot of current knowledge

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Clinical characteristics of 2019 novel coronavirus infection in China

Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China

Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea

Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster

Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR

A Well Infant with Coronavirus Disease 2019 with High Viral Load

Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerging microbes & infections 2020

Coronavirus infections and immune responses

novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Covid-19 and the Digestive System

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Consistent detection of 2019 novel coronavirus in saliva

Study on the virus transmission based on data analysis of confirmed cases of COVID-19 coronavirus in China (III)

Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures

Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. The Lancet Global Health

Quantifying dynamics of SARS-CoV-2 transmission suggests that epidemic control and avoidance is feasible through instantaneous digital contact tracing

The next big threat to global health?

Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient

Interim infection prevention and control recommendations for patients with confirmed coronavirus disease 2019 (COVID-19) or persons under investigation for COVID-19 in healthcare settings

Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery-continuing the service and 'suppressing'the pandemic

Report from the American Society for Microbiology COVID-19 international summit, 23 march 2020: value of diagnostic testing for SARS-CoV-2/COVID-19

Rational use of personal protective equipment for coronavirus disease (COVID-19): interim guidance

Protecting surgical teams during the COVID-19 outbreak: a narrative review and clinical considerations

Protecting healthcare workers from SARS-CoV-2 infection: practical indications

Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. The Lancet

Immunogenicity and Safety of a Recombinant Adenovirus Type-5-Vectored COVID-19 Vaccine in Healthy Adults

Phase 1/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: interim report

An mRNA vaccine against SARS-CoV-2-preliminary report

The authors declared no conflict of interest in this systematic review.J o u r n a l P r e -p r o o f 

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.Authors declared that there is no conflict of interest to this manuscript

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.No fund is obtained for this review article

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.No patient samples were used J o u r n a l P r e -p r o o f Consent Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions.Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.No studies on patients has been done and this is a review article

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways, should be listed as contributors. J o u r n a l P r e -p r o o f

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.You can register any type of research at http://www.researchregistry.com to obtain your UIN if you have not already registered. This is mandatory for human studies only. Trials and certain observational research can also be registered elsewhere such as: ClinicalTrials.gov or ISRCTN or numerous other registries.There is no human participants and this is a review article

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publishProf. Dr. Heshu Sulaiman Rahman, E.mail: heshu.rhaman@univsul.edu.iq Tel: 009647726159590